SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-24-090781
Filing Date
2024-04-09
Accepted
2024-04-09 16:05:58
Documents
5
Period of Report
2024-05-23

Document Format Files

Seq Description Document Type Size
1 DEF 14A d798120ddef14a.htm DEF 14A 594575
2 GRAPHIC g798120g17d21.jpg GRAPHIC 27792
3 GRAPHIC g798120g89a99.jpg GRAPHIC 38454
4 GRAPHIC g798120g94g94.jpg GRAPHIC 157262
5 GRAPHIC g798120g95g95.jpg GRAPHIC 181468
  Complete submission text file 0001193125-24-090781.txt   1146491
Mailing Address 100 CAMBRIDGEPARK DRIVE SUITE 101 CAMBRIDGE MA 02140
Business Address 100 CAMBRIDGEPARK DRIVE SUITE 101 CAMBRIDGE MA 02140 617-655-6580
Vor Biopharma Inc. (Filer) CIK: 0001817229 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39979 | Film No.: 24832743
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)